Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Analyst Ratings
Moderate Buy
7 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GDRX Stock 12 Month Forecast
Average Price Target
$6.61
▲(42.46% Upside)
| Highest Price Target$9.00 | Average Price Target$6.61 | Lowest Price Target$4.75 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
Reiterated
03/03/25
Bank of America Securities
Reiterated
02/28/25
Morgan Stanley
Reiterated
02/28/25
Wells Fargo
Reiterated
02/28/25
Truist Financial
Reiterated
02/28/25
Raymond James
Reiterated
02/27/25
Citi
Reiterated
02/27/25
Leerink Partners
Reiterated
02/27/25
TD Cowen
Reiterated
02/27/25
RBC Capital
Reiterated
02/27/25
KeyBanc
$7→$6
Buy
29.31%
Upside
Reiterated
01/08/25
GoodRx price target lowered to $6 from $7 at KeyBancGoodRx price target lowered to $6 from $7 at KeyBanc
J.P. Morgan
$7
Buy
50.86%
Upside
Reiterated
11/26/24
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (NASDAQ: IONS) and GoodRx Holdings (NASDAQ: GDRX)
UBS
$8.5→$6
Hold
29.31%
Upside
Reiterated
11/11/24
GoodRx Holdings Inc. (GDRX) PT Lowered to $6 at UBSUBS analyst Kevin Caliendo lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.00 (from $8.50) while maintaining a Neutral rating.
Robert W. Baird
$7→$5
Hold
7.76%
Upside
Reiterated
11/11/24
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at BairdBaird analyst Vikram Kesavabhotla lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $5.00 (from $7.00) while maintaining a Neutral rating.
Barclays
$6
Buy
29.31%
Upside
Reiterated
11/11/24
GoodRx Holdings (GDRX) Gets a Buy from Barclays
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
Reiterated
03/03/25
Bank of America Securities
Reiterated
02/28/25
Morgan Stanley
Reiterated
02/28/25
Wells Fargo
Reiterated
02/28/25
Truist Financial
Reiterated
02/28/25
Raymond James
Reiterated
02/27/25
Citi
Reiterated
02/27/25
Leerink Partners
Reiterated
02/27/25
TD Cowen
Reiterated
02/27/25
RBC Capital
Reiterated
02/27/25
KeyBanc
$7→$6
Buy
29.31%
Upside
Reiterated
01/08/25
GoodRx price target lowered to $6 from $7 at KeyBancGoodRx price target lowered to $6 from $7 at KeyBanc
J.P. Morgan
$7
Buy
50.86%
Upside
Reiterated
11/26/24
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (NASDAQ: IONS) and GoodRx Holdings (NASDAQ: GDRX)
UBS
$8.5→$6
Hold
29.31%
Upside
Reiterated
11/11/24
GoodRx Holdings Inc. (GDRX) PT Lowered to $6 at UBSUBS analyst Kevin Caliendo lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.00 (from $8.50) while maintaining a Neutral rating.
Robert W. Baird
$7→$5
Hold
7.76%
Upside
Reiterated
11/11/24
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at BairdBaird analyst Vikram Kesavabhotla lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $5.00 (from $7.00) while maintaining a Neutral rating.
Barclays
$6
Buy
29.31%
Upside
Reiterated
11/11/24
GoodRx Holdings (GDRX) Gets a Buy from Barclays
GDRX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
13
18
15
9
4
Buy
3
2
6
7
7
Hold
8
11
11
8
5
Sell
2
3
3
3
2
Strong Sell
0
0
0
0
0
total
26
34
35
27
18
Each month's total comprises the sum of three months' worth of ratings.
GDRX Financial Forecast
GDRX Stock Forecast FAQ
What is GDRX’s average 12-month price target, according to analysts?
Based on analyst ratings, GoodRx Holdings’s 12-month average price target is $6.61.
What is GDRX’s upside potential, based on the analysts’ average price target?
GoodRx Holdings has 42.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GDRX a Buy, Sell or Hold?
GoodRx Holdings has a consensus rating of Moderate Buy which is based on 7 buy ratings, 3 hold ratings and 1 sell ratings.
What is GoodRx Holdings’s price target?
The average price target for GoodRx Holdings is $6.61. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $4.75. The average price target represents 42.46% Increase from the current price of $4.64.
The highest analyst price target is $9.00 ,the lowest forecast is $4.75. The average price target represents 42.46% Increase from the current price of $4.64.
What do analysts say about GoodRx Holdings?
GoodRx Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of GDRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.